- Published at
- by seekingalpha.com
mixed
mixed
Losses Mount At InnoCare But Cash Cushion Dulls The Pain (undefined:INCPF)
InnoCare's drug sales soared after its key product was approved for Chinese medical insurance coverage, but hefty foreign exchange losses pushed the accounts into the red. Read more.